Timothy James Ley is an American hematologist and cancer biologist. He is the Lewis T. and Rosalind B. Apple Professor of Oncology in the department of medicine, and former chief of the section of stem cell biology in the division of oncology at Washington University in St. Louis. He is the co-director of the Oliver Langenberg Physician-Scientist Training Program in the Department of Medicine, and is a member of the Alvin J. Siteman Cancer Center. In 2026, he was elected to the American Philosophical Society.
Ley's research group focuses on the genetics and genomics of acute myeloid leukemia (AML). His lab studies the development of normal and leukemic blood cells. His work is focused on identifying the mutations and epigenetic events that are responsible for the initiation and progression of AML."Cancer gene complexity revealed." "BBC News". 7 August 2009.
Ley led the team that sequenced the first cancer genome (from an AML patient)."Experts Decode Cancer Patient's Genes, Seeking Treatment Clues." New York Times. 6 November 2008. He has gone on to develop projects that will use whole genome sequencing to help diagnose and treat patients with AML."In Treatment for Leukemia, Glimpses of the Future." "New York Times". 7 July 2012.
To better understand the role of many of the mutations discovered through whole genome sequencing of leukemias, he and his colleagues have constructed several mouse models of AML, which are very similar to human AML.Siteman Cancer Center History Dr. Ley's laboratory has also helped to define the roles of granzymes for the functions of cytotoxic and regulatory T cells.Siteman Cancer Center Profile
Ley grew up in Lakota, Iowa. He received his B.A. degree from Drake University in 1974, and his M.D. from Washington University School of Medicine in 1978. He did his internship and residency in Medicine at Massachusetts General Hospital, was a clinical associate at the NHLBI (National Heart, Lung, and Blood Institute), a Hematology-Oncology Fellow at Washington University Medical Center, and a senior investigator at the NHLBI before moving to Washington University in 1986.
In 2015, Ley was appointed to the National Cancer Advisory Board News from the National Academy of Sciences by President Obama.President Obama Announces More Key Administration Posts Ley was the recipient of the Leopold Griffuel Prize Leopold Griffuel Prize for Basic Science in 2022.
Awards and honors Recipient, Leopold Griffuel Prize for Basic Science, Fondation ARC, Paris, France, 2022 Elected, National Academy of Sciences, 2019 Alfred G. Knudson Prize for Cancer Genetics, National Cancer Institute, 2015 Recipient, The Erasmus Hematology Award, Erasmus MC, 2015 Recipient, E. Donnall Thomas Prize, American Society of Hematology, 2012 Recipient, The George Engelmann Interdisciplinary Award, Academy of Science, St. Louis, 2012 Elected, American Academy of Arts and Sciences, 2010 Treasurer, Association of American Physicians, 2007–2012 Elected, National Academy of Medicine, 2003 Fellow, American Association for the Advancement of Science, 2002 President, American Society for Clinical Investigation, 1997–1998
References
External links Divisions of Hematology and Oncology Ley PubMed Citations "Cancer gene complexity revealed." BBC News. 7 August 2009.